Profil
Isaac Devash worked as Director at Scinai Immunotherapeutics Ltd. from 2017 to 2021.
Education includes an MBA from Harvard University and an undergraduate degree from The Wharton School of the University of Pennsylvania.
Aktiva positioner av Isaac Devash
| Företag | Position | Start |
|---|---|---|
aMoon Ventures Y Sh Ltd.
aMoon Ventures Y Sh Ltd. Investment ManagersFinance aMoon Ventures invests in companies located in Israel. The firm focuses on life-sciences, biopharma, digital health and medical technology companies. It provides financing for early and late stage capital requirements with an investment size of USD 10 - 30 million. The firm makes follow-on investments and also acts as lead investor. | Privat kapitalinvesterare | - |
Tidigare kända positioner av Isaac Devash
| Företag | Position | Slut |
|---|---|---|
| BIONDVAX PHARMACEUTICALS LTD | Direktör/Styrelseledamot | 2021-12-27 |
Isaac Devashs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd. Pharmaceuticals: OtherHealth Technology Operates as a biopharmaceutical company that develops, manufactures and commercializes immunomodulation therapies for infectious diseases | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
aMoon Ventures Y Sh Ltd.
aMoon Ventures Y Sh Ltd. Investment ManagersFinance aMoon Ventures invests in companies located in Israel. The firm focuses on life-sciences, biopharma, digital health and medical technology companies. It provides financing for early and late stage capital requirements with an investment size of USD 10 - 30 million. The firm makes follow-on investments and also acts as lead investor. | Finance |
















